<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33772353</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?</ArticleTitle><Pagination><StartPage>2211</StartPage><EndPage>2222</EndPage><MedlinePgn>2211-2222</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-021-05188-0</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIM" NlmCategory="OBJECTIVE">Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by the degeneration of both upper and lower motoneurons in the brain and spinal cord leading to motor and extra-motor symptoms. Although traditionally considered a pure motor disease, recent evidences suggest that ALS is a multisystem disorder. Neuropsychological alterations, in fact, are observed in more than 50% of patients: while executive dysfunctions have been firstly identified, alterations in verbal fluency, behavior, and pragmatic and social cognition have also been described. Detecting and monitoring ALS cognitive and behavioral impairment even at early disease stages is likely to have staging and prognostic implications, and it may impact the enrollment in future clinical trials. During the last 10 years, humoral, radiological, neurophysiological, and genetic biomarkers have been reported in ALS, and some of them seem to potentially correlate to cognitive and behavioral impairment of patients. In this review, we sought to give an up-to-date state of the art of neuropsychological alterations in ALS: we will describe tests used to detect cognitive and behavioral impairment, and we will focus on promising non-invasive biomarkers to detect pre-clinical cognitive decline.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To date, the research on humoral, radiological, neurophysiological, and genetic correlates of neuropsychological alterations is at the early stage, and no conclusive longitudinal data have been published. Further and longitudinal studies on easily accessible and quantifiable biomarkers are needed to clarify the time course and the evolution of cognitive and behavioral impairments of ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>De Marchi</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ALS Center &amp; Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Carrarini</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>De Martino</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University "Magna Graecia", Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Diamanti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fasano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, "V.Fazzi" Hospital, A.S.L. Lecce, Lecce, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lupica</LastName><ForeName>Antonino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, Palermo, Sicily, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Russo</LastName><ForeName>Mirella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Salemme</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Interdepartmental Center of Neuroscience and Neurotechnologies (CfNN), University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Spinelli</LastName><ForeName>Edoardo Gioele</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neuroimaging Research Unit, Division of Neuroscience, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bombaci</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3961-6780</Identifier><AffiliationInfo><Affiliation>"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy. ale.bombaci@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SIgN</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">ALS-bi</Keyword><Keyword MajorTopicYN="N">ALS-cbi</Keyword><Keyword MajorTopicYN="N">ALS-ci</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Cognitive alteration</Keyword><Keyword MajorTopicYN="N">Cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">Pre-clinical</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33772353</ArticleId><ArticleId IdType="pmc">PMC8159827</ArticleId><ArticleId IdType="doi">10.1007/s10072-021-05188-0</ArticleId><ArticleId IdType="pii">10.1007/s10072-021-05188-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Prim 3(1):17071. 10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17(1):17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82(7):740 LP&#x2013;740746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, Shefner J, for The WFN Research Group On ALS/MND A revision of the El Escorial criteria-2015. Amyotroph Lateral Scler Front Degener. 2015;16(5-6):291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi V, Bombaci A, Zampedri L, Lu CH, Malik B, Zetterberg H, Heslegrave AJ, Rinaldi C, Greensmith L, Hanna MG, Malaspina A, Fratta P. Plasma pNfH levels differentiate SBMA from ALS. J Neurol Neurosurg Psychiatry. 2019;91:215&#x2013;217. doi: 10.1136/jnnp-2019-320624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320624</ArticleId><ArticleId IdType="pubmed">31575607</ArticleId></ArticleIdList></Reference><Reference><Citation>Caga J, Hsieh S, Lillo P, Dudley K, Mioshi E (2019) The impact of cognitive and behavioral symptoms on ALS patients and their caregivers. Front Neurol 10. 10.3389/fneur.2019.00192</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6421295</ArticleId><ArticleId IdType="pubmed">30915018</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, Hortob&#xe1;Gyi T, Rosenfeld J, Silani V, Ince PG, Turner MR. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Front Degener. 2017;18(3-4):153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Raaphorst J, Beeldman E, De Visser M, De Haan RJ, Schmand B. A systematic review of behavioural changes in motor neuron disease. Amyotroph Lateral Scler. 2012;13(6):493&#x2013;501. doi: 10.3109/17482968.2012.656652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.656652</ArticleId><ArticleId IdType="pubmed">22424127</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S. Executive dysfunction in ALS is not the whole story. J Neurol Neurosurg Psychiatry. 2013;84(5):474&#x2013;475. doi: 10.1136/jnnp-2012-303851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303851</ArticleId><ArticleId IdType="pubmed">23117493</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, Hardiman O. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76(14):1263&#x2013;1269. doi: 10.1212/WNL.0b013e318214359f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318214359f</ArticleId><ArticleId IdType="pubmed">21464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper E, Schuster C, Machts J, Bittner D, Vielhaber S, Benecke R, Teipel S, Prudlo J. Dysexecutive functioning in ALS patients and its clinical implications. Amyotroph Lateral Scler Front Degener. 2015;16(3-4):160&#x2013;171. doi: 10.3109/21678421.2015.1026267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1026267</ArticleId><ArticleId IdType="pubmed">25967541</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto-Grau M, Hardiman O, Pender N (2018) The study of language in the amyotrophic lateral sclerosis - frontotemporal spectrum disorder: a systematic review of findings and new perspectives. Neuropsychol Rev 28(2):251&#x2013;268. 10.1007/s11065-018-9375-7</Citation><ArticleIdList><ArticleId IdType="pubmed">29705950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, B&#xf6;hm S, M&#xfc;ller HP, Aho-&#xd6;zhan H, Keller J, Gorges M, Loose M, Weishaupt JH, Uttner I, Pinkhardt E, Kassubek J, del Tredici K, Braak H, Abrahams S, Ludolph AC. Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis. Cortex. 2018;101:163&#x2013;171. doi: 10.1016/j.cortex.2018.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2018.01.004</ArticleId><ArticleId IdType="pubmed">29477906</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Siciliano M, Russo A, et al. Theory of mind and its neuropsychological and quality of life correlates in the early stages of amyotrophic lateral sclerosis. Front Psychol. 2016;7(DEC):1&#x2013;11. doi: 10.3389/fpsyg.2016.01934.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2016.01934</ArticleId><ArticleId IdType="pmc">PMC5149517</ArticleId><ArticleId IdType="pubmed">28018269</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovic R, Stephenson L, Colville S, Swingler R, Chandran S, Abrahams S. Multidimensional apathy in ALS: validation of the dimensional apathy scale. J Neurol Neurosurg Psychiatry. 2016;87(6):663&#x2013;669. doi: 10.1136/jnnp-2015-310772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310772</ArticleId><ArticleId IdType="pubmed">26203157</ArticleId></ArticleIdList></Reference><Reference><Citation>Caga J, Hsieh S, Highton-Williamson E, Zoing MC, Ramsey E, Devenney E, Ahmed RM, Kiernan MC. Apathy and its impact on patient outcome in amyotrophic lateral sclerosis. J Neurol. 2018;265(1):187&#x2013;193. doi: 10.1007/s00415-017-8688-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8688-4</ArticleId><ArticleId IdType="pubmed">29189922</ArticleId></ArticleIdList></Reference><Reference><Citation>Femiano C, Trojsi F, Caiazzo G, Siciliano M, Passaniti C, Russo A, Bisecco A, Cirillo M, Monsurr&#xf2; MR, Esposito F, Tedeschi G, Santangelo G. Apathy is correlated with widespread diffusion tensor imaging (DTI) impairment in amyotrophic lateral sclerosis. Behav Neurol. 2018;2018:1&#x2013;10. doi: 10.1155/2018/2635202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/2635202</ArticleId><ArticleId IdType="pmc">PMC6217902</ArticleId><ArticleId IdType="pubmed">30425751</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Sarnelli MF, Solara V, Bersano E, Cantello R, Mazzini L (2019) Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurol Scand 139(5). 10.1111/ane.13073</Citation><ArticleIdList><ArticleId IdType="pubmed">30712314</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Carelli L, Faini A, Solca F, Meriggi P, Lafronza A, Ciringione L, Pedroli E, Ticozzi N, Ciammola A, Cipresso P, Riva G, Silani V. The Arrows and Colors Cognitive Test (ACCT): a new verbal-motor free cognitive measure for executive functions in ALS. PLoS One. 2018;13(8):1&#x2013;15. doi: 10.1371/journal.pone.0200953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0200953</ArticleId><ArticleId IdType="pmc">PMC6084851</ArticleId><ArticleId IdType="pubmed">30091987</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, Monti A, Zago S, Calini D, Tiloca C, Doretti A, Verde F, Ratti A, Ticozzi N, Abrahams S, Silani V. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS) Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(7-8):489&#x2013;498. doi: 10.1080/21678421.2016.1183679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1183679</ArticleId><ArticleId IdType="pubmed">27219526</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, Katz JS. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS) Amyotroph Lateral Scler Off Publ World Fed Neurol Res Gr Mot Neuron Dis. 2010;11(3):303&#x2013;311. doi: 10.3109/17482961003727954.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003727954</ArticleId><ArticleId IdType="pubmed">20433413</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory JM, McDade K, Bak TH, Pal S, Chandran S, Smith C, Abrahams S. Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS. J Neurol Neurosurg Psychiatry. 2019;91:149&#x2013;157. doi: 10.1136/jnnp-2019-320807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320807</ArticleId><ArticleId IdType="pmc">PMC6996101</ArticleId><ArticleId IdType="pubmed">31515300</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Z, Irish M, Piguet O, Kiernan MC, Hodges JR, Burrell JR. Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia&#x2013;motor neuron disease patients. J Neurol. 2019;266(4):921&#x2013;933. doi: 10.1007/s00415-019-09216-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09216-0</ArticleId><ArticleId IdType="pubmed">30707358</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage S, Hsieh S, Leslie F, Foxe D, Piguet O, Hodges JR. Distinguishing subtypes in primary progressive aphasia: application of the Sydney language battery. Dement Geriatr Cogn Disord. 2013;35(3-4):208&#x2013;218. doi: 10.1159/000346389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000346389</ArticleId><ArticleId IdType="pubmed">23467307</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop DVM. Comprehension of spoken, written and signed sentences in childhood language disorders. J Child Psychol Psychiatry. 1982;23(1):1&#x2013;20. doi: 10.1111/j.1469-7610.1982.tb00045.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7610.1982.tb00045.x</ArticleId><ArticleId IdType="pubmed">6174536</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F, Migliaccio R, Santamar&#xed;a-Garc&#xed;a H, Santangelo G, Trojsi F. Social cognition dysfunctions in neurodegenerative diseases: neuroanatomical correlates and clinical implications. Behav Neurol. 2018;2018:1&#x2013;18. doi: 10.1155/2018/1849794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1849794</ArticleId><ArticleId IdType="pmc">PMC5944290</ArticleId><ArticleId IdType="pubmed">29854017</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron-Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I. The &#x201c;Reading the Mind in the Eyes&#x201d; test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry. 2001;42(2):241&#x2013;251. doi: 10.1111/1469-7610.00715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-7610.00715</ArticleId><ArticleId IdType="pubmed">11280420</ArticleId></ArticleIdList></Reference><Reference><Citation>Abell F, Happ&#xe9; F, Frith U. Do triangles play tricks? Attribution of mental states to animated shapes in normal and abnormal development. Cogn Dev. 2000;15(1):1&#x2013;16. doi: 10.1016/S0885-2014(00)00014-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0885-2014(00)00014-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambini V, Bischetti L, Bonomi CG, Arcara G, Lecce S, Ceroni M. Beyond the motor account of amyotrophic lateral sclerosis: verbal humour and its relationship with the cognitive and pragmatic profile. Int J Lang Commun Disord. 2020;55(5):751&#x2013;764. doi: 10.1111/1460-6984.12561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1460-6984.12561</ArticleId><ArticleId IdType="pubmed">32725835</ArticleId></ArticleIdList></Reference><Reference><Citation>Strikwerda-Brown C, Ramanan S, Irish M. Neurocognitive mechanisms of theory of mind impairment in neurodegeneration: a transdiagnostic approach. Neuropsychiatr Dis Treat. 2019;15:557&#x2013;573. doi: 10.2147/NDT.S158996.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S158996</ArticleId><ArticleId IdType="pmc">PMC6388953</ArticleId><ArticleId IdType="pubmed">30863078</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischetti L, Ceccato I, Lecce S, Cavallini E, Bambini V (2019) Pragmatics and theory of mind in older adults&#x2019; humor comprehension. Curr Psychol. 10.1007/s12144-019-00295-w</Citation></Reference><Reference><Citation>Arcara G, Bambini V. A test for the Assessment of Pragmatic Abilities and Cognitive Substrates (APACS): normative data and psychometric properties. Front Psychol. 2016;7:70. doi: 10.3389/fpsyg.2016.00070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2016.00070</ArticleId><ArticleId IdType="pmc">PMC4751735</ArticleId><ArticleId IdType="pubmed">26903894</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, Raaphorst J, Izumi Y, et al. Cognitive and behavioral status in Japanese ALS patients: a multicenter study. J Neurol. 2020;267(5):1321&#x2013;1330. doi: 10.1007/s00415-019-09655-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09655-9</ArticleId><ArticleId IdType="pubmed">31955246</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovic R, Stephenson L, Newton J, Crockford C, Swingler R, Chandran S, Abrahams S. Multidimensional apathy and executive dysfunction in amyotrophic lateral sclerosis. Cortex. 2017;94:142&#x2013;151. doi: 10.1016/j.cortex.2017.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2017.06.023</ArticleId><ArticleId IdType="pubmed">28759804</ArticleId></ArticleIdList></Reference><Reference><Citation>Carelli L, Solca F, Faini A, et al. The complex interplay between depression/anxiety and executive functioning: insights from the ECAS in a large ALS Population. Front Psychol. 2018;9(APR):1&#x2013;8. doi: 10.3389/fpsyg.2018.00450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2018.00450</ArticleId><ArticleId IdType="pmc">PMC5895754</ArticleId><ArticleId IdType="pubmed">29674987</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna K, Lynch C, McLaughlin RL, Iyer PM, O'Brien C, Phukan J, Wynne B, Bokde AL, Bradley DG, Pender N, al-Chalabi A, Hardiman O. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012;11(3):232&#x2013;240. doi: 10.1016/S1474-4422(12)70014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70014-5</ArticleId><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M, Dalla Bella E, Nigri A, Pinardi C, Demichelis G, Porcu L, Gellera C, Pensato V, Cappa SF, Bruzzone MG, Lauria G, Ferraro S. Cognitive syndromes and C9orf72 mutation are not related to cerebellar degeneration in amyotrophic lateral sclerosis. Front Neurosci. 2019;13:440. doi: 10.3389/fnins.2019.00440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00440</ArticleId><ArticleId IdType="pmc">PMC6524613</ArticleId><ArticleId IdType="pubmed">31133784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Costello E, Doherty MA, et al. Cognitive dysfunction in pre-symptomatic C9orf72 carriers (1774) Neurology. 2020;94(15 Supplement):1774.</Citation></Reference><Reference><Citation>Montembeault M, Sayah S, Rinaldi D, le Toullec B, Bertrand A, Funkiewiez A, Saracino D, Camuzat A, Couratier P, Chouly M, Hannequin D, Aubier-Girard C, Pasquier F, Delbeuck X, Colliot O, Batrancourt B, Azuar C, L&#xe9;vy R, Dubois B, le Ber I, Migliaccio R. Cognitive inhibition impairments in presymptomatic C9orf72 carriers. J Neurol Neurosurg Psychiatry. 2020;3:1&#x2013;7. doi: 10.1136/jnnp-2019-322242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322242</ArticleId><ArticleId IdType="pubmed">32054668</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, van Minkelen R, Rombouts SA, Cardoso MJ, Clegg S, Espak M, Mead S, Thomas DL, de Vita E, Masellis M, Black SE, Freedman M, Keren R, MacIntosh BJ, Rogaeva E, Tang-Wai D, Tartaglia MC, Laforce R, Jr, Tagliavini F, Tiraboschi P, Redaelli V, Prioni S, Grisoli M, Borroni B, Padovani A, Galimberti D, Scarpini E, Arighi A, Fumagalli G, Rowe JB, Coyle-Gilchrist I, Graff C, Fallstr&#xf6;m M, Jelic V, St&#xe5;hlbom AK, Andersson C, Thonberg H, Lilius L, Frisoni GB, Binetti G, Pievani M, Bocchetta M, Benussi L, Ghidoni R, Finger E, Sorbi S, Nacmias B, Lombardi G, Polito C, Warren JD, Ourselin S, Fox NC, Rossor MN. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14(3):253&#x2013;262. doi: 10.1016/S1474-4422(14)70324-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70324-2</ArticleId><ArticleId IdType="pmc">PMC6742501</ArticleId><ArticleId IdType="pubmed">25662776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, Sias AC, Mandelli ML, Brown JA, Brown AB, Khazenzon AM, Vidovszky AA, Zanto TP, Karydas AM, Pribadi M, Dokuru D, Coppola G, Geschwind DH, Rademakers R, Gorno-Tempini ML, Rosen HJ, Miller BL, Seeley WW. Network degeneration and dysfunction in presymptomatic C9Orf72 expansion carriers. NeuroImage Clin. 2017;14:286&#x2013;297. doi: 10.1016/j.nicl.2016.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.12.006</ArticleId><ArticleId IdType="pmc">PMC5349617</ArticleId><ArticleId IdType="pubmed">28337409</ArticleId></ArticleIdList></Reference><Reference><Citation>Papma JM, Jiskoot LC, Panman JL, Dopper EG, den Heijer T, Donker Kaat L, Pijnenburg YAL, Meeter LH, van Minkelen R, Rombouts SARB, van Swieten JC. Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion. Neurology. 2017;89(12):1256&#x2013;1264. doi: 10.1212/WNL.0000000000004393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004393</ArticleId><ArticleId IdType="pubmed">28855404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand A, Wen J, Rinaldi D, Houot M, Sayah S, Camuzat A, Fournier C, Fontanella S, Routier A, Couratier P, Pasquier F, Habert MO, Hannequin D, Martinaud O, Caroppo P, Levy R, Dubois B, Brice A, Durrleman S, Colliot O, le Ber I, for the Predict to Prevent Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis (PREV-DEMALS) Study Group Early cognitive, structural, and microstructural changes in presymptomatic C9orf72 carriers younger than 40 years. JAMA Neurol. 2018;75(2):236&#x2013;245. doi: 10.1001/jamaneurol.2017.4266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4266</ArticleId><ArticleId IdType="pmc">PMC5838615</ArticleId><ArticleId IdType="pubmed">29197216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; DE, M&#xfc;ller H-P, Finsel J, Weydt P, Knehr A, Winroth I, Andersen P, Weishaupt J, Uttner I, Kassubek J, Ludolph AC. Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers&#x2014;a developmental disorder. J Neurol Neurosurg Psychiatry. 2020;91(11):1195&#x2013;1200. doi: 10.1136/jnnp-2020-323671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323671</ArticleId><ArticleId IdType="pmc">PMC7569387</ArticleId><ArticleId IdType="pubmed">32855285</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, McMillan CT, Brettschneider J, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84(2):163&#x2013;169. doi: 10.1136/jnnp-2012-303507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303507</ArticleId><ArticleId IdType="pmc">PMC3543474</ArticleId><ArticleId IdType="pubmed">23117491</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Boot B, Kuntz KM, Gavrilova R, Reeves A, Whitwell J, Kantarci K, Jack CR, Jr, Parisi JE, Lucas JA, Petersen RC, Rademakers R. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9Orf72. Brain. 2012;135(Pt 3):765&#x2013;783. doi: 10.1093/brain/aws004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws004</ArticleId><ArticleId IdType="pmc">PMC3286335</ArticleId><ArticleId IdType="pubmed">22366793</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeve BF, Gra-Radford NR. Cognitive and behavioral features of c9ftd/als. Alzheimers Res Ther. 2012;4:29. doi: 10.1186/alzrt132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt132</ArticleId><ArticleId IdType="pmc">PMC3506943</ArticleId><ArticleId IdType="pubmed">22817642</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AMT, Jones M, Gerhard A, Davidson YS, Robinson A, Gibbons L, Hu Q, DuPlessis D, Neary D, Mann DMA, Pickering-Brown SM. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9Orf72 mutations. Brain. 2012;135(3):693&#x2013;708. doi: 10.1093/brain/awr355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr355</ArticleId><ArticleId IdType="pmc">PMC3286329</ArticleId><ArticleId IdType="pubmed">22300873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiung GYR, Dejesus-Hernandez M, Feldman HH, et al. Clinical and pathological features of familial frontotemporal dementia caused by C9Orf72 mutation on chromosome 9p. Brain. 2012;135(3):709&#x2013;722. doi: 10.1093/brain/awr354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr354</ArticleId><ArticleId IdType="pmc">PMC3286328</ArticleId><ArticleId IdType="pubmed">22344582</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, Warren JD. Frontotemporal dementia with the C9Orf72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain. 2012;135(Pt 3):736&#x2013;750. doi: 10.1093/brain/awr361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr361</ArticleId><ArticleId IdType="pmc">PMC3286330</ArticleId><ArticleId IdType="pubmed">22366791</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel AN, Sampson JB (2015) Cognitive profile of C9orf72 in frontotemporal dementia and amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep 15(9). 10.1007/s11910-015-0582-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26198888</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Santangelo G, Caiazzo G, Siciliano M, Ferrantino T, Piccirillo G, Femiano C, Cristillo V, Monsurr&#xf2; MR, Esposito F, Tedeschi G. Neuropsychological assessment in different King&#x2019;s clinical stages of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2016;17(3-4):228&#x2013;235. doi: 10.3109/21678421.2016.1143513.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1143513</ArticleId><ArticleId IdType="pubmed">26905940</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, Barberis M, Corrado L, D'Alfonso S, Bersano E, Sarnelli MF, Solara V, Zucchetti JP, Peotta L, Iazzolino B, Mazzini L, Mora G, Calvo A. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93(10):e984&#x2013;e994. doi: 10.1212/WNL.0000000000008063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008063</ArticleId><ArticleId IdType="pmc">PMC6745732</ArticleId><ArticleId IdType="pubmed">31409738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilani M, Micallef J, Soubrouillard C, Rey-Lardiller D, Dematte&#xef; C, Dib M, Philippot P, Ceccaldi M, Pouget J, Blin O. A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord. 2004;5(1):46&#x2013;54. doi: 10.1080/14660820310017560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310017560</ArticleId><ArticleId IdType="pubmed">15204024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper E, Zydatiss K, Schuster C, Machts J, Bittner D, Kaufmann J, Benecke R, Vielhaber S, Teipel S, Prudlo J. No change in executive performance in ALS patients: a longitudinal neuropsychological study. Neurodegener Dis. 2016;16(3-4):184&#x2013;191. doi: 10.1159/000440957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000440957</ArticleId><ArticleId IdType="pubmed">26613522</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, O'Brien C, Phukan J, Lynch C, Pender N, Hardiman O. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology. 2013;80(17):1590&#x2013;1597. doi: 10.1212/WNL.0b013e31828f18ac.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31828f18ac</ArticleId><ArticleId IdType="pubmed">23553481</ArticleId></ArticleIdList></Reference><Reference><Citation>Bersano E, Sarnelli MF, Solara V et al (2020) Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study. Amyotroph Lateral Scler Front Degener 1&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">32484726</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, Faini A, Madotto F, Lafronza A, Monti A, Zago S, Ciammola A, Ratti A, Ticozzi N, Abrahams S, Silani V. Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS Screen (ECAS) Amyotroph Lateral Scler Front Degener. 2018;19(5-6):387&#x2013;395. doi: 10.1080/21678421.2018.1473443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1473443</ArticleId><ArticleId IdType="pubmed">29804470</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Weishaupt JH. Update on amyotrophic lateral sclerosis genetics. Curr Opin Neurol. 2019;32(5):735&#x2013;739. doi: 10.1097/WCO.0000000000000737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000737</ArticleId><ArticleId IdType="pubmed">31335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamosh A, Scott AF, Amberger J, Bocchini C, Valle D, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2002;30(1):52&#x2013;55. doi: 10.1093/nar/30.1.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/30.1.52</ArticleId><ArticleId IdType="pmc">PMC99152</ArticleId><ArticleId IdType="pubmed">11752252</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, DeJesus-Hernandez M, Niemantsverdriet E, Murray ME, Heckman MG, Diehl NN, Brown PH, Baker MC, Finch NCA, Bauer PO, Serrano G, Beach TG, Josephs KA, Knopman DS, Petersen RC, Boeve BF, Graff-Radford NR, Boylan KB, Petrucelli L, Dickson DW, Rademakers R. Association between repeat sizes and clinical and pathological characteristics in carriers of C9Orf72 repeat expansions (Xpansize-72): a cross-sectional cohort study. Lancet Neurol. 2013;12(10):978&#x2013;988. doi: 10.1016/S1474-4422(13)70210-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70210-2</ArticleId><ArticleId IdType="pmc">PMC3879782</ArticleId><ArticleId IdType="pubmed">24011653</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium PMALSS, Tazelaar GHP, van Rheenen W, et al. Chchd10 variants in amyotrophic lateral sclerosis: where is the evidence? Ann Neurol. 2018;84(1):110&#x2013;116. doi: 10.1002/ana.25273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25273</ArticleId><ArticleId IdType="pmc">PMC6553489</ArticleId><ArticleId IdType="pubmed">30014597</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino E, Rainero I, Chi&#xf2; A, et al. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology. 2012;79(15):1556&#x2013;1562. doi: 10.1212/WNL.0b013e31826e25df.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826e25df</ArticleId><ArticleId IdType="pmc">PMC3655323</ArticleId><ArticleId IdType="pubmed">22972638</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J, Gijselinck I, Van Mossevelde S, et al. TBK1 mutation spectrum in an extended European patient cohort with frontotemporal dementia and amyotrophic lateral sclerosis. Hum Mutat. 2017;38(3):297&#x2013;309. doi: 10.1002/humu.23161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23161</ArticleId><ArticleId IdType="pmc">PMC5324646</ArticleId><ArticleId IdType="pubmed">28008748</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Topp S, Yang S, et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Commun. 2016;7(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835537</ArticleId><ArticleId IdType="pubmed">27080313</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder V, Gregory JM, Barria MA, Green A, Pal S. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. BMC Neurol. 2018;18(1):90. doi: 10.1186/s12883-018-1091-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1091-7</ArticleId><ArticleId IdType="pmc">PMC6027783</ArticleId><ArticleId IdType="pubmed">29954341</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortob&#xe1;gyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science (80- ) 2009;323(5918):1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S, Che C, Feng S, et al. Novel mutation in optineurin causing aggressive ALS+/&#x2212; frontotemporal dementia. Ann Clin Transl Neurol. 2019;6(12):2377&#x2013;2383. doi: 10.1002/acn3.50928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50928</ArticleId><ArticleId IdType="pmc">PMC6917321</ArticleId><ArticleId IdType="pubmed">31838784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S-C, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14(9):544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchi E, Bonetto V, Sorar&#xf9; G et al (2020) Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol Neurodegener 15(1). 10.1186/s13024-020-00406-3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7559190</ArticleId><ArticleId IdType="pubmed">33059698</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AG, Gray E, Bampton A, Raciborska D, Talbot K, Turner MR. CSF chitinase proteins in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(11):1215&#x2013;1220. doi: 10.1136/jnnp-2019-320442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320442</ArticleId><ArticleId IdType="pubmed">31123140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ill&#xe1;n-Gala I, Alcolea D, Montal V, Dols-Icardo O, Mu&#xf1;oz L, de Luna N, Tur&#xf3;n-Sans J, Cort&#xe9;s-Vicente E, S&#xe1;nchez-Saudin&#xf3;s MB, Subirana A, Sala I, Blesa R, Clarim&#xf3;n J, Fortea J, Rojas-Garc&#xed;a R, Lle&#xf3; A. CSF sAPP&#x3b2;, YKL-40, and NfL along the ALS-FTD spectrum. Neurology. 2018;91(17):E1619&#x2013;E1628. doi: 10.1212/WNL.0000000000006383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006383</ArticleId><ArticleId IdType="pubmed">30291183</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Phan K, Highton-Williamson E, Strikwerda-Brown C, Caga J, Ramsey E, Zoing M, Devenney E, Kim WS, Hodges JR, Piguet O, Halliday GM, Kiernan MC. Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia. Ann Clin Transl Neurol. 2019;6(3):486&#x2013;495. doi: 10.1002/acn3.721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.721</ArticleId><ArticleId IdType="pmc">PMC6414477</ArticleId><ArticleId IdType="pubmed">30911572</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Lee A, Nouwens A, Henderson RD, McCombe PA. Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects. Amyotroph Lateral Scler Front Degener. 2018;19(5-6):362&#x2013;376. doi: 10.1080/21678421.2018.1433689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1433689</ArticleId><ArticleId IdType="pubmed">29384411</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P, Huss A, Mayer B, Grehl T, Grosskreutz J, Borck G, Kuhle J, Lul&#xe9; D, Meyer T, Oeckl P, Petri S, Weishaupt J, Ludolph AC, Otto M. Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net. Amyotroph Lateral Scler Front Degener. 2017;18(1-2):112&#x2013;119. doi: 10.1080/21678421.2016.1241279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1241279</ArticleId><ArticleId IdType="pubmed">27819158</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremolizzo L, Pellegrini A, Conti E, Arosio A, Gerardi F, Lunetta C, Magni P, Appollonio I, Ferrarese C. BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis. Neurodegener Dis. 2016;16(3-4):192&#x2013;198. doi: 10.1159/000441916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000441916</ArticleId><ArticleId IdType="pubmed">26745714</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmadasa T, Huynh W, Tsugawa J, Shimatani Y, Ma Y, Kiernan MC. Implications of structural and functional brain changes in amyotrophic lateral sclerosis. Expert Rev Neurother. 2018;18(5):407&#x2013;419. doi: 10.1080/14737175.2018.1464912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2018.1464912</ArticleId><ArticleId IdType="pubmed">29667443</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, Murphy J, Shoesmith C, Rosenfeld J, Leigh PN, Bruijn L, Ince P, Figlewicz D. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10(3):131&#x2013;146. doi: 10.1080/17482960802654364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802654364</ArticleId><ArticleId IdType="pubmed">19462523</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, Brunetti M, Ossola I, Lo Presti A, Cammarosano S, Canosa A, Chio A. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86(2):168&#x2013;173. doi: 10.1136/jnnp-2013-307223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307223</ArticleId><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M, Agosta F, Abrahams S, Fazekas F, Grosskreutz J, Kalra S, Kassubek J, Silani V, Turner MR, Masdeu JC, European Federation of Neurological Societies EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol. 2010;17(4):526&#x2013;e20. doi: 10.1111/j.1468-1331.2010.02951.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2010.02951.x</ArticleId><ArticleId IdType="pmc">PMC3154636</ArticleId><ArticleId IdType="pubmed">20136647</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Kasper E, Dyrba M, Machts J, Bittner D, Kaufmann J, Mitchell AJ, Benecke R, Teipel S, Vielhaber S, Prudlo J. Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35(1):240&#x2013;246. doi: 10.1016/j.neurobiolaging.2013.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.07.020</ArticleId><ArticleId IdType="pubmed">23992619</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda M, Senda J, Watanabe H, Epifanio B, Tanaka Y, Imai K, Riku Y, Li Y, Nakamura R, Ito M, Ishigaki S, Atsuta N, Koike H, Katsuno M, Hattori N, Naganawa S, Sobue G. Involvement of the caudate nucleus head and its networks in sporadic amyotrophic lateral sclerosis-frontotemporal dementia continuum. Amyotroph Lateral Scler Front Degener. 2016;17(7-8):571&#x2013;579. doi: 10.1080/21678421.2016.1211151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1211151</ArticleId><ArticleId IdType="pubmed">27684890</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Ferraro PM, Riva N, Spinelli EG, Chi&#xf2; A, Canu E, Valsasina P, Lunetta C, Iannaccone S, Copetti M, Prudente E, Comi G, Falini A, Filippi M. Structural brain correlates of cognitive and behavioral impairment in MND. Hum Brain Mapp. 2016;37(4):1614&#x2013;1626. doi: 10.1002/hbm.23124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23124</ArticleId><ArticleId IdType="pmc">PMC6867462</ArticleId><ArticleId IdType="pubmed">26833930</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M, Dalla Bella E, Contarino VE, Bersano E, Lauria G. Cortical thinning trajectories across disease stages and cognitive impairment in amyotrophic lateral sclerosis. Cortex. 2020;131:284&#x2013;294. doi: 10.1016/j.cortex.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2020.07.007</ArticleId><ArticleId IdType="pubmed">32811660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ill&#xe1;n-Gala I, Montal V, Pegueroles J, et al. Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. Neurology. 2020;95(18):10.1212/WNL.0000000000010727. doi: 10.1212/wnl.0000000000010727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000010727</ArticleId><ArticleId IdType="pmc">PMC7682829</ArticleId><ArticleId IdType="pubmed">32913016</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F, Karavasilis E, Riederer F, Zalonis I, Ferentinos P, Velonakis G, Xirou S, Rentzos M, Argiropoulos G, Zouvelou V, Zambelis T, Athanasakos A, Toulas P, Vadikolias K, Efstathopoulos E, Kollias S, Karandreas N, Kelekis N, Evdokimidis I. Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: a combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis. Brain Imaging Behav. 2018;12(2):547&#x2013;563. doi: 10.1007/s11682-017-9722-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-017-9722-y</ArticleId><ArticleId IdType="pubmed">28425061</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco LMT, de Rezende TJR, Roversi C d O, et al. Brain signature of mild stages of cognitive and behavioral impairment in amyotrophic lateral sclerosis. Psychiatry Res Neuroimaging. 2018;272:58&#x2013;64. doi: 10.1016/j.pscychresns.2017.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pscychresns.2017.11.010</ArticleId><ArticleId IdType="pubmed">29175194</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J, Loewe K, Kaufmann J, Jakubiczka S, Abdulla S, Petri S, Dengler R, Heinze HJ, Vielhaber S, Schoenfeld MA, Bede P. Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology. 2015;85(15):1301&#x2013;1309. doi: 10.1212/WNL.0000000000002017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002017</ArticleId><ArticleId IdType="pubmed">26385880</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimond D, Ishaque A, Chenji S, Mah D, Chen Z, Seres P, Beaulieu C, Kalra S. White matter structural network abnormalities underlie executive dysfunction in amyotrophic lateral sclerosis. Hum Brain Mapp. 2017;38(3):1249&#x2013;1268. doi: 10.1002/hbm.23452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23452</ArticleId><ArticleId IdType="pmc">PMC6866969</ArticleId><ArticleId IdType="pubmed">27796080</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, Proudfoot M, Talbot K, Turner MR. The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis. NeuroImage Clin. 2018;17:953&#x2013;961. doi: 10.1016/j.nicl.2017.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.12.025</ArticleId><ArticleId IdType="pmc">PMC5752097</ArticleId><ArticleId IdType="pubmed">29321969</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Di Nardo F, Siciliano M et al (2020) Frontotemporal degeneration in amyotrophic lateral sclerosis (ALS): a longitudinal MRI one-year study. CNS Spectr 1&#x2013;10. 10.1017/S109285292000005X</Citation><ArticleIdList><ArticleId IdType="pubmed">32089134</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Esposito F, de Stefano M, Buonanno D, Conforti FL, Corbo D, Piccirillo G, Cirillo M, Monsurr&#xf2; MR, Montella P, Tedeschi G. Functional overlap and divergence between ALS and bvFTD. Neurobiol Aging. 2015;36(1):413&#x2013;423. doi: 10.1016/j.neurobiolaging.2014.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.06.025</ArticleId><ArticleId IdType="pubmed">25063233</ArticleId></ArticleIdList></Reference><Reference><Citation>Basaia S, Agosta F, Cividini C, Trojsi F, Riva N, Spinelli EG, Moglia C, Femiano C, Castelnovo V, Canu E, Falzone Y, Monsurr&#xf2; MR, Falini A, Chi&#xf2; A, Tedeschi G, Filippi M. Structural and functional brain connectome in motor neuron diseases: a multicenter MRI study. Neurology. 2020;95(18):e2552&#x2013;e2564. doi: 10.1212/WNL.0000000000010731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010731</ArticleId><ArticleId IdType="pmc">PMC7682834</ArticleId><ArticleId IdType="pubmed">32913015</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu T, Hou Y, Wei Q, Yang J, Luo C, Chen Y, Gong Q, Shang H. Patterns of brain regional functional coherence in cognitive impaired ALS. Int J Neurosci. 2020;130(8):751&#x2013;758. doi: 10.1080/00207454.2019.1705806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2019.1705806</ArticleId><ArticleId IdType="pubmed">31906800</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M, the EANM&#x2010;EAN Task Force for the Prescription of FDG&#x2010;PET for Dementing Neurodegenerative Disorders. Festari C, Altomare D, Gandolfo F, Orini S. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol. 2018;25(10):1201&#x2013;1217. doi: 10.1111/ene.13728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13728</ArticleId><ArticleId IdType="pubmed">29932266</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, Pagani M, Cistaro A, Montuschi A, Iazzolino B, Fania P, Cammarosano S, Ilardi A, Moglia C, Calvo A, Chi&#xf2; A. 18 F-FDG-PET correlates of cognitive impairment in ALS. Neurology. 2016;86(1):44&#x2013;49. doi: 10.1212/WNL.0000000000002242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002242</ArticleId><ArticleId IdType="pubmed">26590270</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhour MS, Doidy F, Mondou A et al (2017) Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis. EJNMMI Res 7(1). 10.1186/s13550-017-0267-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5339262</ArticleId><ArticleId IdType="pubmed">28266002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicks P, Turner MR, Abrahams S, Hammers A, Brooks DJ, Leigh PN, Goldstein LH. Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study. Amyotroph Lateral Scler. 2008;9(1):43&#x2013;49. doi: 10.1080/17482960701737716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701737716</ArticleId><ArticleId IdType="pubmed">18270878</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Ferraro PM, Riva N, Spinelli EG, Domi T, Carrera P, Copetti M, Falzone Y, Ferrari M, Lunetta C, Comi G, Falini A, Quattrini A, Filippi M. Structural and functional brain signatures of C9orf72 in motor neuron disease. Neurobiol Aging. 2017;57:206&#x2013;219. doi: 10.1016/j.neurobiolaging.2017.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.05.024</ArticleId><ArticleId IdType="pubmed">28666709</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Bokde ALW, Byrne S, Elamin M, McLaughlin RL, Kenna K, Fagan AJ, Pender N, Bradley DG, Hardiman O. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology. 2013;81(4):361&#x2013;369. doi: 10.1212/WNL.0b013e31829c5eee.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31829c5eee</ArticleId><ArticleId IdType="pmc">PMC3772833</ArticleId><ArticleId IdType="pubmed">23771489</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter MK, Danielian LE, Braun LE, Wu T. Longitudinal diffusion imaging across the C9orf72 clinical spectrum. J Neurol Neurosurg Psychiatry. 2018;89(1):53&#x2013;60. doi: 10.1136/jnnp-2017-316799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316799</ArticleId><ArticleId IdType="pmc">PMC6454927</ArticleId><ArticleId IdType="pubmed">29054917</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R, Schmidt R, Westeneng HJ, Verstraete E, Seelen M, van Rheenen W, de Reus MA, van Es MA, Hendrikse J, Veldink JH, van den Heuvel MP, van den Berg LH. Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers. Neurology. 2015;85(20):1780&#x2013;1788. doi: 10.1212/WNL.0000000000002135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002135</ArticleId><ArticleId IdType="pubmed">26497991</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl-Schmid J, Licata A, Goldhardt O, et al. FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9Orf72 mutations. Transl Psychiatry. 2019;9(1):54. doi: 10.1038/s41398-019-0381-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0381-1</ArticleId><ArticleId IdType="pmc">PMC6355852</ArticleId><ArticleId IdType="pubmed">30705258</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vocht J, Blommaert J, Devrome M, et al. Use of multimodal imaging and clinical biomarkers in presymptomatic carriers of C9orf72 repeat expansion. JAMA Neurol. 2020;77(8):1008&#x2013;1017. doi: 10.1001/jamaneurol.2020.1087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1087</ArticleId><ArticleId IdType="pmc">PMC7417970</ArticleId><ArticleId IdType="pubmed">32421156</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74(1):20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Sporns O (2019) A cross-disorder connectome landscape of brain dysconnectivity. Nat Rev Neurosci</Citation><ArticleIdList><ArticleId IdType="pubmed">31127193</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Turner MR, Wuu J. Defining pre-symptomatic amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2019;20(5-6):303&#x2013;309. doi: 10.1080/21678421.2019.1587634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1587634</ArticleId><ArticleId IdType="pmc">PMC6613999</ArticleId><ArticleId IdType="pubmed">30892087</ArticleId></ArticleIdList></Reference><Reference><Citation>McMackin R, Bede P, Pender N, Hardiman O, Nasseroleslami B. Neurophysiological markers of network dysfunction in neurodegenerative diseases. NeuroImage Clin. 2019;22:101706. doi: 10.1016/j.nicl.2019.101706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101706</ArticleId><ArticleId IdType="pmc">PMC6370863</ArticleId><ArticleId IdType="pubmed">30738372</ArticleId></ArticleIdList></Reference><Reference><Citation>McMackin R, Dukic S, Broderick M, Iyer PM, Pinto-Grau M, Mohr K, Chipika R, Coffey A, Buxo T, Schuster C, Gavin B, Heverin M, Bede P, Pender N, Lalor EC, Muthuraman M, Hardiman O, Nasseroleslami B. Dysfunction of attention switching networks in amyotrophic lateral sclerosis. NeuroImage Clin. 2019;22:101707. doi: 10.1016/j.nicl.2019.101707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101707</ArticleId><ArticleId IdType="pmc">PMC6365983</ArticleId><ArticleId IdType="pubmed">30735860</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer PM, Mohr K, Broderick M, Gavin B, Burke T, Bede P, Pinto-Grau M, Pender NP, McLaughlin R, Vajda A, Heverin M, Lalor EC, Hardiman O, Nasseroleslami B. Mismatch negativity as an indicator of cognitive sub-domain dysfunction in amyotrophic lateral sclerosis. Front Neurol. 2017;8:395. doi: 10.3389/fneur.2017.00395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00395</ArticleId><ArticleId IdType="pmc">PMC5559463</ArticleId><ArticleId IdType="pubmed">28861032</ArticleId></ArticleIdList></Reference><Reference><Citation>McMackin R, Dukic S, Costello E et al (2020) Localization of brain networks engaged by the sustained attention to response task provides quantitative markers of executive impairment in amyotrophic lateral sclerosis. Cereb Cortex</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391267</ArticleId><ArticleId IdType="pubmed">32318719</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukic S, McMackin R, Buxo T, Fasano A, Chipika R, Pinto-Grau M, Costello E, Schuster C, Hammond M, Heverin M, Coffey A, Broderick M, Iyer PM, Mohr K, Gavin B, Pender N, Bede P, Muthuraman M, Lalor EC, Hardiman O, Nasseroleslami B. Patterned functional network disruption in amyotrophic lateral sclerosis. Hum Brain Mapp. 2019;40(16):4827&#x2013;4842. doi: 10.1002/hbm.24740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24740</ArticleId><ArticleId IdType="pmc">PMC6852475</ArticleId><ArticleId IdType="pubmed">31348605</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, di Iorio R, di Lazzaro V, Ferreri F, Fitzgerald PB, George MS, Hallett M, Lefaucheur JP, Langguth B, Matsumoto H, Miniussi C, Nitsche MA, Pascual-Leone A, Paulus W, Rossi S, Rothwell JC, Siebner HR, Ugawa Y, Walsh V, Ziemann U. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an IFCN Committee. Clin Neurophysiol. 2015;126(6):1071&#x2013;1107. doi: 10.1016/j.clinph.2015.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2015.02.001</ArticleId><ArticleId IdType="pmc">PMC6350257</ArticleId><ArticleId IdType="pubmed">25797650</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Highton-Williamson E, Caga J, Matamala JM, Dharmadasa T, Howells J, Zoing MC, Shibuya K, Geevasinga N, Vucic S, Hodges JR, Ahmed RM, Kiernan MC. Primary lateral sclerosis and the amyotrophic lateral sclerosis&#x2013;frontotemporal dementia spectrum. J Neurol. 2018;265(8):1819&#x2013;1828. doi: 10.1007/s00415-018-8917-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8917-5</ArticleId><ArticleId IdType="pubmed">29868980</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, &#xd6;zdinler PH, Kiernan MC, Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol. 2016;12(11):651&#x2013;661. doi: 10.1038/nrneurol.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A, Dell&#x2019;Era V, Cantoni V, Cotelli MS, Cosseddu M, Spallazzi M, Micheli A, Turrone R, Alberici A, Borroni B. TMS for staging and predicting functional decline in frontotemporal dementia. Brain Stimul. 2020;13(2):386&#x2013;392. doi: 10.1016/j.brs.2019.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2019.11.009</ArticleId><ArticleId IdType="pubmed">31787557</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>